Invitae Corporation (NVTA) News
Filter NVTA News Items
NVTA News Results
|Loading, please wait...|
NVTA News Highlights
- For NVTA, its 30 day story count is now at 9.
- Over the past 21 days, the trend for NVTA's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- PACB, BLI and DECK are the most mentioned tickers in articles about NVTA.
Latest NVTA News From Around the Web
Below are the latest news stories about Invitae Corp that investors may wish to consider to help them evaluate NVTA as an investment opportunity.
The big shareholder groups in Invitae Corporation ( NYSE:NVTA ) have power over the company. Large companies usually...
Analyst estimates suggest these stocks can deliver eye-popping gains once the rest of the stock market views them in the same light.
U.S. District Judge Edward Davila blocked questioning of Theranos' former lab director about his work at another Silicon Valley startup that ran afoul of the law.
What do the world's most confident investors do when their favorite stocks dive along with the rest of the stock market? If you're Cathie Wood, the CEO and founder of ARK Invest you do some bargain shopping. Rising interest rates in the U.S. and a financial crisis in China have been driving down shares of the exchange-traded funds (ETFs) Cathie Wood manages for ARK Invest.
PacBio's (PACB) collaboration with ERGA will help scientists to take the first important step toward creating high-quality genetic maps of each plant and animal species in a reliable manner.
New Study Highlights the Value of Genetic Testing to Guide Clinical Management and Improve Outcomes for Epilepsy Patients
Invitae (NYSE: NVTA), a leading medical genetics company, today presented research demonstrating that genetic findings informed clinical management changes that led to improved seizure control and outcomes in the majority of epilepsy patients with actionable findings. This study underscores the importance of genetic testing for all people with epilepsy and supports the growing evidence that medical genetic testing can improve health outcomes and reduce healthcare costs. The findings were present
PacBio's (PACB) latest acquisition is expected to deliver a differentiated set of products and applications across a wide spectrum of markets.
The following slide deck was published by Invitae Corporation in conjunction with this event....
If you're Cathie Wood, founder, and CEO of ARK Invest, you keep buying more. Shares of life-science equipment manufacturer Berkeley Lights (NASDAQ: BLI) took a hit last week, and two ARK Invest ETFs quickly bought more. Wood also bought two genomics stocks that have tanked this year, Personalis (NASDAQ: PSNL) and Invitae (NYSE: NVTA).
Dante Labs Announces Expansion of its Finance Team with the Appointment of Andre Nel as Chief Financial Officer, Dalila Rahmani as Chief Accounting Officer, Laura D’Angelo as VP Investor Relations and Omar Elbakshish as Senior Director
CAMBRIDGE, United Kingdom, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, today announced the appointments of Andre Nel, Dalila Rahmani, Laura D’Angelo and Omar Elbakshish to the company’s management team, expanding its global leadership to help scale the growing business. “We are thrilled to welcome Andre, Dalila, Laura and Omar to the expanding leadership team here at Dante,” said Andrea Riposati, CEO of Dante Labs. “As we work to deliver a m